Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

A new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid ... Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Having multiple treatment options is the kind of advancement ... showed physical changes that happen in the brain due to Alzheimer’s disease. “Defining diseases by the biology has long been ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer's disease ... more options and greater opportunity to have more time. Having multiple treatment options ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...

The search for answers to Alzheimer's disease and other neurodegenerative disorders remains one of the most pressing goals in brain research. Maciej J. Stawikowski, Ph.D., an assistant professor of ...